Antiplatelet or anticoagulant therapy might not increase the risk of haemoptysis in patients with bronchiectasis

被引：0

作者：

Lee, J. ^{[1
]}

Park, Y. S. ^{[1
]}

Lee, C-H. ^{[1
]}

Lee, S-M. ^{[1
]}

Yoo, C-G. ^{[1
]}

Kim, Y. W. ^{[1
]}

Han, S. K. ^{[1
]}

Yim, J-J ^{[1
]}

机构：

[1] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul 110744, South Korea

来源：

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE | 2013年 / 17卷 / 07期

关键词：

bronchial artery embolisation; aspirin; warfarin; ASPIRIN;

D O I：

10.5588/ijtld.12.0807

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The aim of this study was to assess whether the use of antiplatelets and anticoagulants increased haemoptysis in patients with bronchiectasis. Cases (n = 242) with a history of haemoptysis were compared with controls (n = 242) without a history of haemoptysis. Of the 242 case patients, 16.5% took antiplatelets compared with 19.8% of controls (P = 0.346). The proportion of warfarin users did not differ between cases and controls (3.3% vs. 2.5%, P = 0.588). The use of these agents might not be associated with increased risk of haemoptysis in patients with bronchiectasis.

引用

页码：989 / 991

页数：3

共 50 条

[21] Risk of bleeding with dental implant surgery in patients on anticoagulant or antiplatelet drugs: a systematic review and meta-analysis
Zou, Lilin
Hua, Li
ACTA ODONTOLOGICA SCANDINAVICA, 2023, 81 (02) : 98 - 104
[22] Dual Antiplatelet Therapy in Patients with High Cardiovascular Risk
Espinoza, Clifton
Mukherjee, Debabrata
HEART INTERNATIONAL, 2021, 15 (01): : 26 - 36
[23] Stroke of antiplatelet and anticoagulant therapy in patients with coronary artery disease: a meta-analysis of randomized controlled trials
Shao, Qiao Yu
Wang, Zhi Jian
Ma, Xiao Teng
Lin, Xu Ze
Pan, Liu
Zhou, Yu Jie
BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
[24] Dual antiplatelet therapy in high-risk patients
Van de Werf, Frans
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2007, 9 (0D) : D3 - D9
[25] Direct oral anticoagulant plus antiplatelet therapy: prescribing practices and bleeding outcomes
Tinkham, Tyler T.
Vazquez, Sara R.
Jones, Aubrey E.
Witt, Daniel M.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 49 (03) : 492 - 496
[26] Prolonged double antiplatelet therapy vs association of antiplatelet and low dose of anticoagulant therapy: PEGASUS or COMPASS?
Brunetti, Natale Daniele
De Gennaro, Luisa
Di Biase, Matteo
Caldarola, Pasquale
IJC HEART & VASCULATURE, 2019, 24
[27] Management of Patients with High Gastrointestinal Risk on Antiplatelet Therapy
Cryer, Byron
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2009, 38 (02) : 289 - +
[28] HEMORRHAGIC RISK OF VITREORETINAL SURGERY IN PATIENTS MAINTAINED ON NOVEL ORAL ANTICOAGULANT THERAPY
Grand, M. Gilbert
Walia, Harpreet S.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (02): : 299 - 304
[29] Nonadherence to guidelines for prescribing antiplatelet/anticoagulant therapy in patients with atrial fibrillation
Navarro-Juan, Miguel
Carbonell-Torregrosa, Maria A.
Palazon-Bru, Antonio
Martinez-Diaz, Ana M.
Gil-Guillen, Vicente F.
FAMILY PRACTICE, 2016, 33 (03) : 290 - 295
[30] Effect of anticoagulant/antiplatelet therapy on the development and progression of diabetic retinopathy
Chi-Juei Jeng
Yi-Ting Hsieh
Cheng-Li Lin
I-Jong Wang
BMC Ophthalmology, 22

← 1 2 3 4 5 →